MedicubeX and Sartar Therapeutics have completed financing rounds organized by Springvest. Congratulations to the teams!

Autumn 2025 has brought numerous funding announcements from our startups, and this time we’re proud to share two at once. In addition to both rounds being organized in collaboration with Finnish investment service company Springvest Oyj, the companies share another noteworthy feature: both were selected to Health Incubator Helsinki’s very first batch in 2020.

€3.4M for MedicubeX

MedicubeX’s self-check stations have already become a familiar sight in several Finnish public health stations and private clinics. Users step into the soundproof booth, and a few minutes later leave with a full set of vital sign readings and, for example, an assessment of their risk for conditions such as cardiovascular disease and type 2 diabetes.

Currently, the Helsinki-based company has clients in Finland, Germany, the United Kingdom, Estonia, and Latvia. MedicubeX’s innovation has convinced investors time and again, with the €3.4 million share issue completed with Springvest Oyj as the latest proof.

Sartar Therapeutics collected €4.7M

Sartar Therapeutics tackles hard-to-treat cancers that have lacked new treatment options for decades. The company’s drug candidate SAR003 holds orphan drug designations from both EMA and FDA for gastrointestinal stromal tumors. This autumn, Sartar also secured an additional orphan designation from the FDA, this time for soft tissue sarcomas.

The latest funding of €4.7 million allows Sartar to move into Phase I and IIa clinical trials, and as the company notes in its announcement, preparations are already well underway.

Encouraging signs of growth 

According to the freshly released Startup Study 2025, the number of new startups in Finland has decreased since the peak pandemic years, and access to early-stage funding has become more difficult. At the same time, there are reasons for optimism: the Finnish Venture Capital Association recently reported that Finnish startups have raised funding at a record pace this year.

“We’re seeing this positive trend in Health Incubator Helsinki, too. Actually, this year is becoming our strongest one yet in terms of the funding raised by our startups,” says Christian Lardot, Incubator Lead. “Our startups have raised a total of 17.7 million euros so far this year”, he adds. 

“Both Sartar and MedicubeX joined Health Incubator Helsinki in 2020, the year the incubator was established. It has been rewarding to see how both companies have progressed and succeeded in securing funding and developing their businesses. The most rewarding part of running the incubator is seeing the companies we have selected succeed”, Lardot says.